Trinity Biotech Plc (TRIB)
0.7038
+0.01
(+0.99%)
USD |
NASDAQ |
Jan 21, 16:00
0.7069
0.00 (0.00%)
Pre-Market: 20:00
Trinity Biotech Cash from Investing (Quarterly): -1.462M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp. Plc | -12.29M |
| DBV Technologies SA | -0.2404M |
| Ascendis Pharma A/S | -0.2594M |
| Cellectis SA | -3.266M |
| Akari Therapeutics Plc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.0714M |
| Cash from Financing (Quarterly) | 1.337M |
| Free Cash Flow | -9.604M |
| Free Cash Flow Per Share (Quarterly) | -0.0822 |
| Free Cash Flow to Equity (Quarterly) | -6.176M |
| Free Cash Flow to Firm (Quarterly) | 2.795M |
| Free Cash Flow Yield | -79.29% |